16 patents currently held
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Dec 2031. from the record
Of the 4 now held by other companies, 2 name Universität Basel as their current owner, and 2 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Dec 2031
Next term end
15
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Nov 2038 · High confidence
Also notable
Ends May 2035 · High confidence
Also notable
Ends Dec 2038 · High confidence
Allele Editing and Applications Thereof
US 11,499,168
Cited by 4 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2038.
Bacteria-Based Protein Delivery
US 11,702,663
Cited by 5 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2035. A terminal disclaimer caps this term to an earlier patent's.
Nanomechanical Profiling of Breast Cancer Molecular Subtypes
US 11,686,720
The newest of the three, granted 2023. It anchors the portfolio to 2038, later than anything else here.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 27, 2026The maintenance fee for Nanomechanical Profiling of Breast Cancer Molecular Subtypes (US 11,686,720) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 1 fee due Jan 18, 2027The maintenance fee for Bacteria-Based Protein Delivery (US 11,702,663) comes due Jan 18, 2027. Unpaid by Jul 19, 2027, it lapses early.
- 2 fees due Jul 2 to 26, 2027 · next Jul 2
- 1 fee due Aug 18, 2027The maintenance fee for Measuring Device and Method for Determining Mass And/Or Mechanical Properties of a Biological System (US 10,564,182) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
What they patent
The 5 largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Nanomechanical Profiling of Breast Cancer Molecular Subtypes | 2 in force | to Dec 2038 |
| Triazine Derivative as Reversible and Irreversible Covalent Inhibitors of PI3K | 1 in force | to Apr 2042 |
| Lossless Cryo-Grid Preparation by Controlled Sample Evaporation | 1 in force | to Jan 2041 |
| Allele Editing and Applications Thereof | 1 in force | to Nov 2038 |
| MHC Class Ia Fusion Dimers for Treatment of Cancer | 1 in force | to Feb 2038 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,756,711 | Method for Staging Cancer Progression by Afm In force · High confidence | In force | High confidence | |
| US 9,244,095 | Method and Device for Controlling a Scanning Probe Microscope In force · High confidence | In force | High confidence | |
| US 9,500,670 | Method and Device for Controlling a Scanning Probe Microscope In force · High confidence | In force | High confidence | |
| US 9,971,000 | Simple Microwave Field Imaging Device In force · High confidence | In force | High confidence | |
| US 11,702,663 | Bacteria-Based Protein Delivery In force · High confidence | In force | High confidence | |
| US 11,422,074 | Lossless Cryo-Grid Preparation Stage for High-Resolution Electron Microscopy In force · High confidence | In force | High confidence | |
| US 10,564,182 | Measuring Device and Method for Determining Mass And/Or Mechanical Properties of a Biological System In force · High confidence | In force | High confidence | |
| US 12,196,740 | Nanomechanical Profiling of Breast Cancer Molecular Subtypes In force · Medium confidence | In force | Medium confidence | |
| US 11,166,987 | Virulence Attenuated Bacteria For Treatment Of Malignant Solid Tumors In force · High confidence | In force | High confidence | |
| US 11,369,660 | Method of Treating Cancer with an HLA-B57 Open Conformer In force · High confidence | In force | High confidence |
Also on record, not counted in the 16: 4 patents in force now held by others · 3 patents ended · 7 applications pending · 6 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.